PNTG - Pennant Group Inc Market Capitalization-to-Revenue Ratio

Corporate company logo of Pennant Group Inc (PNTG)

The Pennant Group, Inc. (PNTG) benefits from the aging US population and government support for home health care, although fixed Medicare rates limit its pricing power. The current P/S valuation on GURU.Markets illustrates the price-to-sales dynamics, where 1.10 represents the current level of the metric. Business growth relies on an IT platform that handles back-office operations, simplifying the scaling of its local agency network.

Pennant Group Inc (PNTG) - P/S Multiple from 07/04/2022 to 11/15/2026

Metric breakdowns and analytics for The Pennant Group (PNTG)

- current quotes and average value forecast:
Market Price Pennant Group Inc|PNTG - Consensus Target
- market capitalization statistics:
Market Value The Pennant Group|PNTG - Total Company Value
- book capitalization indicators:
Share Book Value The Pennant Group|PNTG - Book Capitalization|Market-to-Book Ratio pennantgroup.com|PNTG - Aggregate Company Assets
- issuer credit burden and liquidity indicators:
Debt to Equity Ratio The Pennant Group, Inc.|PNTG - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio The Pennant Group, Inc.|PNTG - Company Aggregate Debts|Debts to Book Capitalization The Pennant Group|PNTG - Company Long-Term Debt|Company Short-Term Indebtedness The Pennant Group|Intermediate Liquidity Ratio pennantgroup.com
- earnings and valuation multiples indicators:
PNTG - Net Income|Expected Net Income The Pennant Group, Inc.|PNTG - P/E Multiple|Forward Price to Earnings Multiple The Pennant Group Corp|PNTG - Price/Earnings to Growth Ratio|Business Value to Operating Income Before Depreciation The Pennant Group|PNTG - Profit before payment of interest, taxes and amortization|Net earnings per one share for the last twelve months The Pennant Group|PNTG - Net earnings per share for the last 12 months|Quarterly EPS earnings growth pennantgroup.com|PNTG - Earnings per share growth in current year|Net earnings per share change forecast for next year The Pennant Group, Inc.
- issuer revenue and sales details:
PNTG - Company Sales|Company Future Revenue The Pennant Group|PNTG - P/S Multiple|Market Cap to Expected Sales Ratio The Pennant Group|PNTG - Sales Growth YoY (Last Twelve Months)
General company analysis:PNTG Pennant Group
Manufactured products of pennantgroup.com

Stable demand for The Pennant Group, Inc. (PNTG) rehabilitation services, which remains independent of economic cycles, makes the company's revenue a reliable foundation for business valuation. This ratio correlates market capitalization with annual income in real-time, allowing investors to identify asset overvaluation or market anomalies by analyzing the price-to-sales chart to determine the fair value of the shares.

Competitors of The Pennant Group, Inc.

HCA (HCA Healthcare) - Market Capitalization-to-Revenue Ratio|Tenet Healthcare Corporation - Market Cap to Revenue|Fresenius Medical (FMS) - Price to Sales|Solventum Corp - P/S Multiple|Price-to-Sales Ratio EHC|Universal Health Services (UHS) - Price-to-Revenue Ratio|DaVita - Market Capitalization-to-Revenue Ratio|Market Cap to Revenue RDNT|OPCH: Market Capitalization-to-Revenue Ratio|Market Cap to Revenue SGRY (Surgery Partners, Inc.)|PINC (Premier, Inc.) - Market Capitalization-to-Revenue Ratio|National Vision - Market Cap to Revenue|Price-to-Revenue Coefficient Progyny Inc (PGNY)|Ardent Health - P/S Multiple|Price-to-Revenue Coefficient Select Medical Corp SEM|ASTH: P/S Multiple|Market Cap to Revenue Ratio MD|USPH (US Physical Therapy Inc) - P/S Multiple|Organogenesis Holdings Inc. (ORGO) - Price-to-Revenue Coefficient|Market Cap to Revenue NUTX (Nutex Health Corp)|AUNA (Auna Health) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio sbc-holdings.com SBC|evolus.com - Price-to-Revenue Ratio|Community Health Systems, Inc. - P/S Multiple|SKIN: Price-to-Revenue Ratio|MDWD: P/S Multiple|BTMD: Market Cap to Sales Volume|Market Cap to Revenue JYNT|Price to Sales DocGo Inc. DCGO|PIII (P3 Health Partners, Inc.) - Price-to-Revenue Coefficient|GANX (Gain Therapeutics) - Market Capitalization-to-Revenue Ratio|P/S Multiple EUDA (EUDA Health Holdings)|BMGL (Basel Medical Group Limited) - Price-to-Sales Ratio|CLGN - Price-to-Revenue Ratio|Price to Sales cuprina.com.sg|CCM: P/S Multiple|AMS: Market Cap to Sales Volume|MRM (MEDIROM Corp) - P/S Multiple|ALBT: Market Capitalization-to-Revenue Ratio|P/S Multiple DHAI|Longevity Health Holdings - Market Cap to Revenue Ratio|Price-to-Revenue Ratio NewGenIvf Group Ltd NIVF|ATIP (atipt.com) - Price-to-Sales Ratio|CMAX: Market Cap to Revenue|Price to Sales Kindly Health|ModivCare (MODV) - Price-to-Revenue Ratio|NVOS (novointegrated.com) - Price-to-Revenue Ratio|SSY (SunLink Health Systems Inc.) - P/S Multiple|BACK (IMAC Holdings Inc) - Market Cap to Sales Volume